# |
Query |
Results |
S97 |
S3 AND S96 |
1131 |
S96 |
S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36 OR S37 OR S38 OR S39 OR S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 OR S48 OR S49 OR S50 OR S51 OR S52 OR S53 OR S54 OR S55 OR S56 OR S57 OR S58 OR S59 OR S60 OR S61 OR S62 OR S63 OR S64 OR S65 OR S66 OR S67 OR S68 OR S69 OR S70 OR S71 OR S72 OR S73 OR S74 OR S75 OR S76 OR S77 OR S78 OR S79 OR S80 OR S81 OR S82 OR S83 OR S84 OR S85 OR S86 OR S87 OR S88 OR S89 OR S90 OR S91 OR S92 OR S93 OR S94 OR S95 |
341775 |
S95 |
TX urinary peptide* |
1598 |
S94 |
TX (VDBP or vitamin D‐binding protein*) |
134 |
S93 |
TX cytokeratin‐19 |
109 |
S92 |
TX (Luteinizing Hormone* or LH) |
18041 |
S91 |
(MH "Diagnosis, Laboratory+") |
101773 |
S90 |
"Keratin‐19" |
2 |
S89 |
(MH "Platelet‐Derived Growth Factor") |
394 |
S88 |
(MH "Epidermal Growth Factors") |
1264 |
S87 |
(MH "Interleukins") |
6584 |
S86 |
(MH "Cytokines") |
6860 |
S85 |
TX Vitamin D‐Binding Protein |
131 |
S84 |
(MH "Vascular Endothelial Growth Factor A") |
194 |
S83 |
TX (endometri* N2 biops*) |
432 |
S82 |
TX (endometri* adj2 biops*) |
0 |
S81 |
TX genomic$ |
7487 |
S80 |
TX proteomic* |
2434 |
S79 |
TX microRNA |
824 |
S78 |
TX microarray |
3123 |
S77 |
TX (PGP 95 or PGP95 or protein gene product*) |
9925 |
S76 |
TX (Annexin 1 or Annexin1) |
472 |
S75 |
TX (ANXA 1 or ANXA1) |
41 |
S74 |
TX cysteine‐rich heparin‐binding protein* |
12 |
S73 |
(MH "Protein Array Analysis") |
73 |
S72 |
TX cyr61 |
34 |
S71 |
TX MTMMP* |
0 |
S70 |
TX progesterone receptor* |
1927 |
S69 |
TX estrogen receptor* |
5193 |
S68 |
TX Aromatase P450 |
38 |
S67 |
TX Cadherin* |
900 |
S66 |
TX Selectin* |
28411 |
S65 |
TX Integrin* |
1587 |
S64 |
TX cell adhesion molecule* |
1578 |
S63 |
TX CAMs |
550 |
S62 |
TX Endometrial marker* |
54 |
S61 |
TX Fas ligand |
338 |
S60 |
TX (TNF‐a or tumour necrosis factor* alfa) |
1489 |
S59 |
TX (MIF or migration inhibitory factor*) |
399 |
S58 |
TX (MCP‐I or monocyte chemoattractant protein‐I) |
13 |
S57 |
TX interleukin |
13809 |
S56 |
TX (Anti‐2HSG or Heremans‐Schmidt glycoprotein) |
7 |
S55 |
TX Anti‐LDL |
9 |
S54 |
TX Anti‐transferrin |
3 |
S53 |
TX Anti‐Thomsen Friedenreich antigen* |
1 |
S52 |
TX Anti‐thyroid |
109 |
S51 |
TX Anti‐laminin‐1 |
15 |
S50 |
TX (HLA or human leucocyte antigen*) |
4202 |
S49 |
(MM "HLA Antigens") |
638 |
S48 |
TX Antiphospholipid* |
1249 |
S47 |
TX Anti‐endometrial |
34 |
S46 |
(MH "Antibodies/BL/DU") |
1294 |
S45 |
TX Autoantibodies |
4385 |
S43 |
TX Total complement level |
3 |
S42 |
TX (T helper* or T supressor*) |
2341 |
S41 |
TX Immune cells alteration* |
24 |
S40 |
TX natural killer t‐cells |
669 |
S39 |
(MM "T Lymphocytes") |
2404 |
S38 |
TX (sEselectin or soluble E‐selectin) |
91 |
S37 |
TX (sEcadherin or soluble E‐cadherin) |
8 |
S36 |
TX sVCAM |
100 |
S35 |
TX sICAM |
173 |
S34 |
TX Soluble adhesion molecule |
368 |
S33 |
TX soluble intercellular adhesion |
237 |
S32 |
(MM "Cell Adhesion Molecules") |
52 |
S31 |
TX Osteopontin* |
416 |
S30 |
TX Follistatin |
74 |
S29 |
TX serum placental protein* |
11 |
S28 |
TX (Ca‐19‐9 or Ca19‐9 or cancer antigen 19‐9) |
262 |
S27 |
TX (Ca‐125 or Ca125 or cancer antigen 125) |
831 |
S26 |
(MM "Glycoproteins/BL/DU") |
224 |
S25 |
TX tissue inhibitor of metalloproteinase |
423 |
S24 |
TX TIMP* |
1845 |
S23 |
TX MMP* |
4244 |
S22 |
TX matrix metalloproteinase* |
3325 |
S21 |
TX Proteolytic enzyme* |
1461 |
S20 |
(MM "Progesterone/BL/DU") |
51 |
S19 |
TX leptin* |
3258 |
S18 |
(MM "Luteinizing Hormone/BL/DU") |
38 |
S17 |
TX (VEGF or vascular endothelial growth factor*) |
7166 |
S16 |
TX (EGFR or epidermal growth factor receptor*) |
6188 |
S15 |
TX (TGF‐b or transforming growth factor beta or TGFb) |
2972 |
S14 |
TX (TGF‐a or transforming growth factor alfa or TGFa) |
464 |
S13 |
TX (IGF‐I or insulin‐like growth factor* or IGF1) |
3588 |
S12 |
TX (EGF or epidermal growth factor*) |
6250 |
S11 |
TX (PDGF or platelet derived growth factor*) |
3195 |
S10 |
TX (FGF or fibroblast growth factor*) |
3395 |
S9 |
TX hepatocyte growth factor* |
880 |
S8 |
TX cytokine* |
20821 |
S7 |
TX scatter factor* |
1864 |
S6 |
TX growth factor* |
76163 |
S5 |
TX Laboratory Test* |
82732 |
S4 |
TX (biomarker* or marker*) |
84857 |
S3 |
S1 OR S2 |
2841 |
S2 |
TX Endometrio* |
2841 |
S1 |
(MM "Endometriosis") |
889 |
S4 |
TX (biomarker* or marker*) |
61,794 |
S3 |
S1 OR S2 |
2,174 |
S2 |
TX Endometrio* |
2,174 |
S1 |
(MM "Endometriosis") |
1,306 |